← Leaderboards
Angela M. Brodie
University Of Maryland Baltimore
$7,232,468
Attributed
$7,232,468
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $648.2K · FY2005–14$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$7,232,468 · 2
VA$0 · 1
By mechanism
R01$7,232,468 · 2
I01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Stuart K Amateau$119,995
- Ke Ren$10,649,004
- Anne W Hamburger$3,712,195
Others in their field
Top investigators on “Athymic Mouse”
- Thomas F Deuel · Beth Israel Deaconess Medical Center$7,283,721
- Ralph Weissleder · Massachusetts General Hospital$5,688,124
- Donald P McDonnell · Duke University$5,386,390
- Oliver W. Press · Fred Hutchinson Cancer Research Center$5,178,285
- Channing J Der · University Of North Carolina Chapel Hill$4,926,790
- Murray Korc · University Of California Irvine$4,764,672
Research focus
Athymic MouseOxidoreductase InhibitorNonhuman Therapy EvaluationTissue /Cell CultureNeoplasm /Cancer ChemotherapyAndrogen ReceptorHuman TissueAntineoplasticsInhibitor/AntagonistEstrogen ReceptorsAromataseTumorNeoplastic ProcessBaseApoptosisRadiotracerDrug Design /Synthesis /ProductionScid MouseResistanceInvestigationAndrogen InhibitorGenetic TranscriptionPharmacokineticsMalignant Neoplasms
Grant awards (32)
New treatment for androgen sensitive and resistant prostate cancer$0
I01 · FY2014 · VA · contact PI
Aromatase and Breast Cancer$282,508
R01 · FY2013 · CA · contact PI
New treatment for androgen sensitive and resistant prostate cancer$0
I01 · FY2013 · VA · contact PI
Aromatase and Breast Cancer$300,541
R01 · FY2012 · CA · contact PI
New treatment for androgen sensitive and resistant prostate cancer$0
I01 · FY2012 · VA · contact PI
Aromatase and Breast Cancer$300,541
R01 · FY2011 · CA · contact PI
Aromatase and Breast Cancer$115,382
R01 · FY2011 · CA · contact PI
New treatment for androgen sensitive and resistant prostate cancer$0
I01 · FY2011 · VA · contact PI
Aromatase and Breast Cancer$309,836
R01 · FY2010 · CA · contact PI
Aromatase and Breast Cancer$115,923
R01 · FY2010 · CA · contact PI
Aromatase and Breast Cancer$309,836
R01 · FY2009 · CA · contact PI
ANDROGEN SYNTHESIS INHIBITORS FOR PROSTATE CANCER$316,811
R01 · FY2008 · CA · contact PI
ANDROGEN SYNTHESIS INHIBITORS FOR PROSTATE CANCER$316,811
R01 · FY2007 · CA · contact PI
Aromatase and Breast Cancer$297,803
R01 · FY2007 · CA · contact PI
ANDROGEN SYNTHESIS INHIBITORS FOR PROSTATE CANCER$326,274
R01 · FY2006 · CA · contact PI
Aromatase and Breast Cancer$306,697
R01 · FY2006 · CA · contact PI
ANDROGEN SYNTHESIS INHIBITORS FOR PROSTATE CANCER$334,125
R01 · FY2005 · CA
Aromatase and Breast Cancer$314,078
R01 · FY2005 · CA
ANDROGEN SYNTHESIS INHIBITORS FOR PROSTATE CANCER$324,522
R01 · FY2004 · CA
Aromatase and Breast Cancer$314,078
R01 · FY2004 · CA
ANDROGEN SYNTHESIS INHIBITORS FOR PROSTATE CANCER$374,908
R01 · FY2003 · CA
Aromatase and Breast Cancer$314,078
R01 · FY2003 · CA
ANDROGEN SYNTHESIS INHIBITORS FOR PROSTATE CANCER$42,748
R01 · FY2003 · CA
ANDROGEN SYNTHESIS INHIBITORS FOR PROSTATE CANCER$363,990
R01 · FY2002 · CA
AROMATASE AND BREAST CANCER$255,615
R01 · FY2002 · CA
ANDROGEN SYNTHESIS INHIBITORS FOR PROSTATE CANCER$41,633
R01 · FY2002 · CA
ANDROGEN SYNTHESIS INHIBITORS FOR PROSTATE CANCER$353,385
R01 · FY2001 · CA
AROMATASE AND BREAST CANCER$248,172
R01 · FY2001 · CA
ANDROGEN SYNTHESIS INHIBITORS FOR PROSTATE CANCER$30,155
R01 · FY2001 · CA
ANDROGEN SYNTHESIS INHIBITORS FOR PROSTATE CANCER$343,096
R01 · FY2000 · CA
AROMATASE AND BREAST CANCER$240,943
R01 · FY2000 · CA
ANDROGEN SYNTHESIS INHIBITORS FOR PROSTATE CANCER$37,979
R01 · FY2000 · CA